Á lódáil...
Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response
Glioblastoma multiforme (GBM) is the most common and most aggressive type of primary brain cancer. Since median overall survival with multimodal standard therapy is only 15 months, there is a clear need for additional effective and long-lasting treatments. Dendritic cell (DC) vaccination is an exper...
Na minha lista:
| Foilsithe in: | Immunotargets Ther |
|---|---|
| Main Authors: | , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Dove Medical Press
2014
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918234/ https://ncbi.nlm.nih.gov/pubmed/27471700 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S40121 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|